Search research articles
Contact Us
Filters
Showing results (31-40 of 89) with videos related to
Page
of 9
Sort By:
Cancer
|
March 6, 2002
The two types of correction of absorbed dose estimates for internal emitters
Lawrence E Williams, An Liu, Dave M Yamauchi, et al.
Protein Engineering
|
December 1, 1987
Expression in COS cells of a mouse-human chimaeric B72.3 antibody
N Whittle, J Adair, C Lloyd, et al.
Plos One
|
November 12, 2015
Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells
Naomi S Sta Maria, Samuel R Barnes, Michael R Weist, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 4, 2000
Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy
J Y Wong, J Wang, A Liu, et al.
Protein Engineering
|
January 26, 2002
Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange
A M Wu, G J Tan, M A Sherman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101
Thomas S C Ng, David Wert, Hargun Sohi, et al.
Anticancer Research
|
May 5, 1999
A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: molecular characterization and biodistributions in normal and tumor bearing mice
M Neumaier, F J Gaida, M R Lewis, et al.
Journal of Immunological Methods
|
May 11, 1984
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma
S K Foung, S Perkins, A Raubitschek, et al.
Cancer Research
|
December 1, 1993
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy
R P Junghans, D Dobbs, M W Brechbiel, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2001
Numerical selection of optimal tumor imaging agents with application to engineered antibodies
L E Williams, A M Wu, P J Yazaki, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 89) with videos related to
Sort By:
Page
of 9
Cancer
|
March 6, 2002
The two types of correction of absorbed dose estimates for internal emitters
Lawrence E Williams, An Liu, Dave M Yamauchi, et al.
Protein Engineering
|
December 1, 1987
Expression in COS cells of a mouse-human chimaeric B72.3 antibody
N Whittle, J Adair, C Lloyd, et al.
Plos One
|
November 12, 2015
Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells
Naomi S Sta Maria, Samuel R Barnes, Michael R Weist, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 4, 2000
Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy
J Y Wong, J Wang, A Liu, et al.
Protein Engineering
|
January 26, 2002
Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange
A M Wu, G J Tan, M A Sherman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101
Thomas S C Ng, David Wert, Hargun Sohi, et al.
Anticancer Research
|
May 5, 1999
A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: molecular characterization and biodistributions in normal and tumor bearing mice
M Neumaier, F J Gaida, M R Lewis, et al.
Journal of Immunological Methods
|
May 11, 1984
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma
S K Foung, S Perkins, A Raubitschek, et al.
Cancer Research
|
December 1, 1993
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy
R P Junghans, D Dobbs, M W Brechbiel, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2001
Numerical selection of optimal tumor imaging agents with application to engineered antibodies
L E Williams, A M Wu, P J Yazaki, et al.
Page
of 9